2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 139 filers reported holding 2SEVENTY BIO INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,767,050 | -61.9% | 450,778 | -1.5% | 0.00% | -100.0% |
| Q2 2023 | $4,633,483 | +29.8% | 457,854 | +30.8% | 0.00% | 0.0% |
| Q1 2023 | $3,569,979 | +6.6% | 349,998 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $3,350,422 | -33.0% | 357,569 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $5,000,000 | +9.0% | 343,631 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $4,586,000 | +21.4% | 347,440 | +57.0% | 0.00% | 0.0% |
| Q1 2022 | $3,777,000 | -33.9% | 221,348 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $5,713,000 | – | 222,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
| Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
| Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
| EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
| Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
| Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
| CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
| Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |